Rolf Vornhagen

Title: Rolf Vornhagen: Innovator in Cytomegalovirus Diagnostics

Introduction

Rolf Vornhagen is a notable inventor based in Langen, Germany. He has made significant contributions to the field of diagnostics, particularly concerning cytomegalovirus. His work has implications for the detection of antibodies, which is crucial for medical diagnostics.

Latest Patents

Vornhagen holds a patent for "Isolated human cytomegalovirus polypeptides and uses thereof." This patent describes diagnostically relevant polypeptides and fusion proteins that originate from cytomegalovirus. These proteins correspond to a region of the major DNA-binding protein or the C-terminal region of the tegument protein pp150. The invention can be utilized in diagnostic tests and methods for detecting IgM antibodies against cytomegalovirus.

Career Highlights

Rolf Vornhagen is associated with Biotest AG, a company that focuses on the development of innovative biopharmaceuticals. His work at Biotest AG has allowed him to contribute to advancements in diagnostic methods and therapeutic solutions.

Collaborations

Throughout his career, Vornhagen has collaborated with notable colleagues, including Walter Hinderer and Hans-H Sonneborn. These collaborations have furthered research and development in the field of cytomegalovirus diagnostics.

Conclusion

Rolf Vornhagen's contributions to the field of diagnostics, particularly through his patent on cytomegalovirus polypeptides, highlight his role as an innovator in medical science. His work continues to impact the way cytomegalovirus infections are diagnosed and managed.